Dr. Agarwal's Eye Hospital Creditors Meeting

The first two lines are not applicable as this is not a results update.

Reader Takeaway: Creditor meeting crucial for merger; potential operational efficiencies.

What just happened

Dr. Agarwal’s Eye Hospital Limited (AEHL) has announced an NCLT-convened meeting for its unsecured creditors on July 2, 2026. The meeting's purpose is to approve the Scheme of Amalgamation with Dr. Agarwal’s Health Care Limited (AHCL).

Why this matters

This meeting is a critical procedural step for the proposed merger. Shareholder and creditor approvals, along with NCLT sanction, are required for the amalgamation to proceed. The merger is intended to create operational efficiencies and a stronger capital structure.

The backstory

AEHL and AHCL are merging to achieve a unified operational and capital structure. Management expects the merger to be earnings per share (EPS) accretive from the first year. The share exchange ratio is 23 equity shares of AHCL for every 2 equity shares of AEHL.

What changes now

If approved by creditors, shareholders, and the NCLT, the companies will amalgamate. Unsecured creditors of both entities will have their liabilities and voting rights considered as part of the scheme. A voting cut-off date of December 31, 2025, has been set.

Risks to watch

Key risks include failure to secure the necessary majority approvals from creditors and shareholders, or if the NCLT does not sanction the scheme. Delays in regulatory approvals could also impact the merger timeline.

Peer comparison

While specific peer merger details are not provided in the filing, industry consolidation often aims for economies of scale and enhanced market presence. This merger appears to follow that trend in the healthcare sector.

Context metrics (time-bound)

As of December 31, 2025:

• AHCL had ₹199.60 crore due to unsecured creditors and ₹73.84 crore to secured creditors.
• AEHL had ₹44.64 crore due to unsecured creditors and ₹85.77 crore to secured creditors.

AEHL's authorized share capital is ₹20 crore, with ₹4.83 crore paid up. AHCL's authorized share capital is ₹90 crore, with ₹31.69 crore paid up.

What to track next

Investors should track the outcome of the unsecured creditors' meeting on July 2, 2026, and subsequent approvals from shareholders and the NCLT. The record date of December 31, 2025, is important for determining voting eligibility.